<DOC>
	<DOCNO>NCT02130674</DOCNO>
	<brief_summary>Severe traumatic brain injury associate life-threatening incapacitating secondary injury . Contemporary therapeutic intervention aim prevent treat secondary damage . In context , improved cerebral metabolism important target modern neurointensive care . The main hypothesis continuous intravenous infusion glutamyl-alanyl dipeptide restores disturb brain metabolism follow severe traumatic brain injury .</brief_summary>
	<brief_title>Optimized Therapy Severe Traumatic Brain Injured Patients</brief_title>
	<detailed_description>Patients suffer severe traumatic brain injury require multimodal neuromonitoring pharmacological coma receive alanyl-glutamine dipeptide ( Dipeptiven ) part standard clinical nutrition . In two group patient influence different duration infusion ( group 1 : 24 hour ; group 2 : 5 day ) investigate . For , pharmacokinetic pharmacodynamic parameter plasma brain determine . Increased plasma glutamine alanine arterial jugular venous plasma cerebral microdialysates reflect efficacy Dipeptiven infusion . Plasma glutamate level well change cerebral glutamate , lactate , lactate/pyruvate ratio , intracranial pressure , bispectral index electroencephalography measure exclude potential adverse effect</detailed_description>
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Brain Injuries</mesh_term>
	<criteria>severe traumatic brain injury prolong pharmacologic coma multimodal neuromonitoring ( microdialysis , ptiO2 ) enteral nutrition patient anticipated decease within 48 hour abdominal injury mass transfusion renal impairment hepatic impairment barbiturate coma parenteral nutrition weight 50 kg weight 100 kg</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>traumatic brain injury</keyword>
	<keyword>glutamine</keyword>
	<keyword>microdialysis</keyword>
	<keyword>metabolism</keyword>
</DOC>